Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
MRI Software Launches 'Workplace Central' in Australia to Enable Hybrid Return to Work Planning 2021-08-30 10:48
GeneQuantum announces Dr. Yi Xia as Senior Vice President of Statistics and Data Science 2021-08-30 10:00
Triad Life Sciences completes A$25m funding round, anticipates ASX listing in coming months 2021-08-30 09:18
FICO Survey: 3 in 5 Malaysian Consumers Will Abandon Long Online Banking Account Applications 2021-08-30 07:00
InnoCare Releases 2021 Half Year Results and Business Highlights 2021-08-29 19:49
TAL Education Group Announces Repurchase of Convertible Senior Notes due 2026 2021-08-28 06:00
Qeeka Home 2021 Interim Revenue Up 66.5% to 524 Million RMB 2021-08-27 22:02
IONOVA Life Science Announces New Financing Round of USD $100 Million 2021-08-27 22:00
China Liberal Cooperates with Enterprises to Provide Graduates with Internship and Employment Service 2021-08-27 21:25
China.org.cn: China's space station: Warm, open new home in outer space 2021-08-27 21:00
CLPS Incorporation Announces Signing of Framework Agreement with A China A-Share Company to Develop Financial IT Services in Domestic Market 2021-08-27 20:30
China Finance Online Announces Changes to the Board of Directors 2021-08-27 20:00
CANGO Auto View: The Time for Automotive-Grade Chips is Now 2021-08-27 18:00
Weidai Ltd. Announces Unaudited Financial Results for the Six Months Ended June 30, 2021 2021-08-27 17:45
Onion Global Launches ZIPLAB 'New Retail' Showroom to Build Closed-loop Ecosystem for Brands 2021-08-27 17:00
Bunshi Lab Starts Accepting Pre-orders for "Bunshi Mask" -- Best-selling Crowdfunded Face Mask in Japan -- through "Indiegogo" Crowdfunding Website 2021-08-27 16:00
Cheetah Mobile to Report Second Quarter 2021 Financial Results on September 7, 2021 2021-08-27 16:00
111, Inc. Announces Second Quarter 2021 Unaudited Financial Results 2021-08-27 14:30
Yili Ranks the 5th in Rabobank's Global Dairy Report 2021-08-27 11:27
Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer 2021-08-27 11:20